Skip to content
Tenfell
Awarded contract
Published 24 Jul 2025

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS England · London

Key facts

Awarded
24 Jun 2025
Contract starts
31 Aug 2025
Contract ends
31 Aug 2027
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 28 suppliers

SupplierValue
CST Pharma Ltd—
Dr Reddy's Laboratories (UK) Ltd—
GlaxoSmithKline—
Janssen-Cilag Ltd—
Orifarm UK—
Pfizer Ltd—
Teva UK Ltd—
Bayer plc—
Seqirus UK Limited—
Amgen Ltd—
Aventis Pharma Ltd T/A Sanofi—
Chugai Pharma Uk Ltd—
Napp Pharmaceuticals—
Sandoz Ltd—
Thornton & Ross Ltd—
Accord-UK Ltd—
AstraZeneca—
Biogen—
Eli Lilly & Company Ltd—
Gedeon Richter UK Ltd—
Merck Serono Limited—
Mylan—
Novo Nordisk—
Roche Products Ltd—
Sun Pharma UK Ltd—
Pharmacosmos UK Ltd—
Vifor Pharma UK Limited—
Manx Healthcare Ltd—

Description

NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 Offer reference number: CM/PHR/24/5718

CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines - Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines - Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.